Aroa Biosurgery Limited Is A New Zealand Based Company Focused On Regenerative Medicineparticularly In Soft Tissue Repair And Wound Healingestablished In 2007 And Listed On The Asxaroa Develops And Manufactures Advanced Medical Products Using Its Proprietary Aroa Ecma C Platformwhich Is Derived From Ovine Forestomach Extracellular Matrix The Company Offers A Range Of Products Designed To Support Wound Healing And Soft Tissue Reconstructionkey Offerings Include Endoformmyriad Matrixmyriad Morcellssymphonyand Reinforced Bioscaffoldsthese Products Are Designed To Promote Cell Migration And Tissue Regenerationaddressing Complex Wounds And Surgical Needsaroa S Products Are Available In Over 95Of U Shospitalsreflecting Its Strong Market Presence And Commitment To Clinical Evidence Generationwith A Focus On Innovation And Cost Effective Outcomesaroa Aims To Improve Patient Care While Targeting Growth In Revenue And Operational Efficiencythe Company Is Led By Ceo Brian Ward And Employs Approximately 261 Staff Globally
